Close menu




March 20th, 2023 | 08:45 CET

Meta Materials and Palantir for the future, what is Commerzbank doing?

  • metamaterials
  • Technology
  • Innovations
Photo credits: pixabay.com

The financial industry is shaking after the collapse of Silicon Valley Bank (SVB) and the problems of Credit Suisse. The rapid rise in interest rates caught banks cold that had bet on long government bonds with low interest rates. SVB had to report losses due to the falling prices of these bonds. As a result, more and more customers withdrew their funds, and the bank was already in trouble, even though the government bonds were supposedly safe. Now the FED is likely to reconsider its interest rate policy. Some market participants even expect the interest rate to be lowered. This plays into the cards of growth companies, which previously suffered from the hikes. We, therefore, highlight Meta Materials and Palantir, two growth companies with innovative technologies, and conclude with a look at Commerzbank.

time to read: 4 minutes | Author: Armin Schulz
ISIN: Meta Materials Inc. | US59134N1046 , PALANTIR TECHNOLOGIES INC | US69608A1088 , COMMERZBANK AG | DE000CBK1001

Table of contents:


    Meta Materials - More than 500 patents filed

    Meta Materials, a company listed on the NASDAQ, has brought new high-performance functional materials and nanocomposites from the laboratory to mass production. Just how innovative the Company is is underscored by the February 15 announcement. Meta Materials has been awarded another US patent for lithium batteries, targeting the use of novel separators such as the NPORE nanoporous ceramic separators. That brings the total number of patents filed to 501, of which 315 have already been granted. The potential applications seem almost unlimited, but the focus at the moment is on optimizing performance and safety in electric cars and in the field of nano-optical safety, which is responsible for most of the revenue.

    The most recent order, dated February 16, came from its G10 central bank customer. The USD 855,000 order is part of a contract for up to USD 41.5 million over an expected five-year period. Nano-optics technology can significantly reduce counterfeit banknotes. The Company plans to enter the global market with its technology in 2023. In battery optimization, the Company is working with DuPont Teijin Films and Mitsubishi Electric Europe to develop series production. PLASMAfusion technology is expected to reduce the weight of the copper foil used in batteries, which accounts for 10% of the weight of a battery cell, by 80%. In this way, both efficiency and safety will be increased, while costs will be saved.

    Sales had increased significantly in previous quarters; however, Q4 sales fell YOY to USD 1.4 million. The Company plans to provide official figures by the end of March, as accounting for the spin-off from Next Bridge Hydrocarbons will take some more time. At the same time, research and further development of technologies consume money. On February 10, it was announced that the Company plans to raise up to USD 100 million via the issuance of shares at the market price. This news sent the share price on a downward slide. The current price is USD 0.4976 per share. If the Company succeeds in optimizing the batteries of electric cars and bringing them into series production, the share should achieve a turnaround.

    Palantir - Analyst expectations exceeded, but share price still falls

    Palantir Technologies is considered one of the most innovative and advanced technology companies in Silicon Valley. Its core competence lies in data analysis, and Palantir has developed software engineering solutions for this purpose. Originally, the platform was used by intelligence agencies. However, the products are now also used by many large companies, government agencies and non-profit organizations to process large amounts of data quickly, accurately and securely. As more and more companies rely on Big Data analytics daily, there is great growth potential. This is evident in the Company's Q4 numbers. The Company posted a positive GAAP net income of USD 31 million and saw total revenue increase 18% YOY to USD 509 million. The number of customers increased 55% YOY and 9% quarter over quarter. In FY2022, total revenue increased 24% YOY to USD 1.91 billion, with US revenue increasing 32% YOY to USD 1.16 billion. Adjusted operating income was USD 421 million, representing a margin of 22%.

    Although this exceeded analysts' expectations, the Company cut 2% of its jobs to adjust to the weaker-growth market environment. On March 8, it announced a contract worth up to USD 99.6 million over 5 years. This will involve providing Palantir software to the Bureau of Medical Services of the US Department of State. Despite the good figures, the share has fallen by more than 20% since the quarterly figures. The share is trading at USD 7.88. That puts the price-to-sales ratio at around 9, which is considered attractive for a growth company.

    Commerzbank - Strong year 2022

    On February 16, Commerzbank reported its financial results for 2022, announcing the highest net profit in more than 10 years. In total, the bank generated around EUR 1.4 billion, exceeding its targets by EUR 400 million. Commerzbank plans to pay a dividend of 20 cents per share and implement a share buyback program of EUR 122 million. For 2023, net income is expected to exceed that of 2022, and a payout ratio to shareholders of 50% is targeted. The transformation into a digital advisory bank is almost complete.

    The world for Commerzbank shareholders was rosy at this point. Rising interest rates also meant rising revenues. But then Silicon Valley Bank's share price plummeted on March 9, and shortly after that, Credit Suisse also ran into trouble. Memories of the 2008 financial crisis were awakened, and the entire banking sector was hit hard. Now the FED's interest rate decision is due this week, and experts are hoping for a cut in the interest rate. That would ease the situation for banks somewhat, but at the same time, such a decision would be bad for Commerzbank's business.

    Currently, bank shares are arguably the hottest item on the stock market because it is often not known how the banks have invested their surplus cash. On the other hand, there are opportunities now. Commerzbank has already done its homework and cut costs. At the same time, European banks are very well capitalized thanks to Basel III regulations. Nevertheless, the Commerzbank share fell by more than 24% at its peak and is currently trading at EUR 9.18. A very attractive level if you want to speculate on a rebound in the banks.


    The growth companies Meta Materials and Palantir are still struggling with profitability. Meta Materials technologies can become real game-changers in many industries in the future. But the Company is not yet making money. Palantir has fought its way into the profit zone and is continuously expanding its customer base. Commerzbank is reporting great figures, but the negative banking environment is dragging down the share. The FED decision on Wednesday is certainly interesting for all three companies.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author



    Related comments:

    Commented by Juliane Zielonka on April 18th, 2024 | 07:00 CEST

    Volkswagen, Altech Advanced Materials, BYD - who can benefit from China's rise

    • Innovations
    • Technology
    • Electromobility
    • Batteries

    Chinese companies such as BYD benefit from state subsidies and domestic access to raw materials. BYD's subsidies have risen from EUR 220 million in just three years to EUR 2.1 billion. These sums are helping BYD dominate the Chinese electric vehicle market and increasingly penetrate the European market. Volkswagen cannot escape the pull of China either. As part of its "In China, for China" strategy, Volkswagen is expanding its cooperation network with Chinese partners. The aim is to reduce costs significantly in the development of EV technology. For companies like Altech Advanced Materials, close cooperation with Chinese market leaders such as BYD and Volkswagen offers the opportunity to commercialize innovative battery technologies that meet the needs of the changing market. One of these innovations, made in Germany by Altech Advanced Materials, increases the longevity of EV batteries by 30%. Here are the details.

    Read

    Commented by Juliane Zielonka on April 11th, 2024 | 07:45 CEST

    Innovation made in Europe: Singulus Technologies, Siemens Energy, BASF - which share offers the greatest potential?

    • renewableenergies
    • chemicals
    • Technology

    Companies in Europe, like Singulus Technologies, are leaders in the production of surface materials in future-oriented sectors such as photovoltaics, semiconductors, medical technology and cosmetics. This is reason enough to take a closer look at Europe as a location. The European Commission is determined to push ahead with CO₂ reduction with all its might and subsidize future energies. They would prefer to lock out Chinese companies that produce solar and wind turbines more cost-effectively than Siemens Energy. However, China is also an excellent place to do business. Chemical giant BASF strategically adheres to long-term contracts, in line with the Chinese strategist Sun Tzu. Which share offers the greatest potential for investors?

    Read

    Commented by André Will-Laudien on April 10th, 2024 | 06:45 CEST

    Attention: Biotech takeovers, after MorphoSys, now Bayer, Vidac Pharma, BioNTech and Pfizer are on the radar

    • Pharma
    • Biotechnology
    • Innovations

    Since the onset of the COVID-19 pandemic, there has been little movement in the biotech sector. However, after a challenging year in 2023, the sector was at least able to start the new year on a solid footing. The surprising takeover of MorphoSys recently got hearts beating again, as Novartis put a whopping EUR 2.7 billion on the table for the cancer specialist from Munich. Only months before, MorphoSys had been traded on the stock exchange at just EUR 700 million. The special market situation in this case was also characterized by the high short ratio, which led to an exorbitant rise in the share price of almost 400% in the final phase. Speculative investors are now keeping a wary eye on potential takeover candidates as the sector is once again attracting considerable attention. We are taking a closer look and searching for the next pearl.

    Read